- Filed
- May 1, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 18, 2025 | 13.07M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $5.91M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $11.25M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $14.04M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $50.9M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $49.07M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $68.53M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $70.89M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $71.1M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $76.13M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $89.93M |
| Total Assets | Q1 2025 · Mar 31, 2024 | $115.03M |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 12.56M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $432K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$11.86M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $55.16M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $62.47M |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | −$0.70 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | −$0.70 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $6.57M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $1.44M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$8.77M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$12.5M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | −$2.11M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $14.7M |
| Revenue | Q1 2025 · Mar 31, 2024 | $12.59M |